Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2023

Jun 20, 2023

33899_dirs_2023-06-20_288f0666-9490-49f3-8245-7b95d0b1168f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-06-15

Reporting Person: Hoer Michael A. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-15 Common Stock A 3118 Acquired 8288.065 Direct

Footnotes

F1: Represents the right to receive 3,118 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.